Literature DB >> 32072376

Factors Associated with Attrition: Analysis of an HIV Clinic in Japan.

Chieko Hashiba1, Mayumi Imahashi2, Junji Imamura3,4, Masashi Nakahata3, Ayumi Kogure3, Hideto Takahashi5, Yoshiyuki Yokomaku3.   

Abstract

This study evaluated the impact of a public medical interpreter on the follow-up clinic attendance rate of foreign-born people with HIV who live in Japan. Participants were patients who visited Nagoya Medical Center from 2009 to 2016. Lost to follow-up was defined as an absence from follow-up visits for more than six months without any notification. A log-rank test was conducted to compare the lost-to-follow-up rates by patients' nation of origin and medical interpreter use. Of the 931 participants, 114 were foreign patients, whose overall attendance rate at 5 years was 75.5%, which was significantly lower than that of Japanese patients (94.1%, p < 0.001). There was no significant difference in regular attendance with respect to medical interpreter use (p = 0.09). Social support in addition to a medical interpreter may be needed to improve attendance rates in the study population.

Entities:  

Keywords:  Health disparity; Language barrier; Medical interpreter; People living with HIV/AIDS

Year:  2021        PMID: 32072376      PMCID: PMC7914243          DOI: 10.1007/s10903-020-00982-y

Source DB:  PubMed          Journal:  J Immigr Minor Health        ISSN: 1557-1912


  7 in total

Review 1.  Meeting the health literacy needs of immigrant populations.

Authors:  Gary L Kreps; Lisa Sparks
Journal:  Patient Educ Couns       Date:  2008-04-02

2.  Projected life expectancy of people with HIV according to timing of diagnosis.

Authors:  Fumiyo Nakagawa; Rebecca K Lodwick; Colette J Smith; Ruth Smith; Valentina Cambiano; Jens D Lundgren; Valerie Delpech; Andrew N Phillips
Journal:  AIDS       Date:  2012-01-28       Impact factor: 4.177

3.  [Factors determining irregular attendance to follow-up visits among human immunodeficiency virus patients: results of the hospital survey of patients infected with human immunodeficiency virus].

Authors:  Asuncion Diaz; Alicia Ten; Henar Marcos; Gonzalo Gutiérrez; Juan González-García; Santiago Moreno; Ana María Barrios; Sari Arponen; Álvaro Portillo; Regino Serrano; Maria Teresa García; José Luis Pérez; Javier Toledo; Maria Carmen Royo; Gustavo González; Ana Izquierdo; Luis Javier Viloria; Irene López; Lázaro Elizalde; Eva Martínez; Daniel Castrillejo; Rosa Aranguren; Caridad Redondo; Mercedes Diez
Journal:  Enferm Infecc Microbiol Clin       Date:  2014-10-23       Impact factor: 1.731

4.  Disclosure behaviour and experienced reactions in patients with HIV versus chronic viral hepatitis or diabetes mellitus in Germany.

Authors:  J M Kittner; F Brokamp; B Jäger; W Wulff; B Schwandt; J Jasinski; H Wedemeyer; R E Schmidt; J M Schattenberg; P R Galle; M Schuchmann
Journal:  AIDS Care       Date:  2013-02-05

5.  Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel.

Authors:  Michael S Saag; Constance A Benson; Rajesh T Gandhi; Jennifer F Hoy; Raphael J Landovitz; Michael J Mugavero; Paul E Sax; Davey M Smith; Melanie A Thompson; Susan P Buchbinder; Carlos Del Rio; Joseph J Eron; Gerd Fätkenheuer; Huldrych F Günthard; Jean-Michel Molina; Donna M Jacobsen; Paul A Volberding
Journal:  JAMA       Date:  2018-07-24       Impact factor: 56.272

6.  Errors in medical interpretation and their potential clinical consequences in pediatric encounters.

Authors:  Glenn Flores; M Barton Laws; Sandra J Mayo; Barry Zuckerman; Milagros Abreu; Leonardo Medina; Eric J Hardt
Journal:  Pediatrics       Date:  2003-01       Impact factor: 7.124

7.  Clinic Attendance for Antiretroviral Pills Pick-Up among HIV-Positive People in Nepal: Roles of Perceived Family Support and Associated Factors.

Authors:  Rakesh Ayer; Kimiyo Kikuchi; Mamata Ghimire; Akira Shibanuma; Madhab Raj Pant; Krishna C Poudel; Masamine Jimba
Journal:  PLoS One       Date:  2016-07-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.